Critical Care Nurses' Knowledge of Correct Line Types for Administration of Common Intravenous Medications: Assessment and Intervention Study. | JMIR Formative Research | 2022 |
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis | | |
Public and Population Health Genomics | | 2016 |
Special populations: Treatment resistant mood disorders | Mental Health Clinician | 2014 |
Cancer Based Pharmacogenomics Network for Drug Repurposing | Lecture Notes in Computer Science | 2014 |
Buprenorphine for opioid dependence: Are there really differences between the formulations? | Mental Health Clinician | 2014 |
Skin Toxicities due to Biotherapy | | |
Risk Management | | |
Data Analysis, Report Writing, and Regulatory Documentation | | |
Phenytoin and Other Hydantoins | | 2010 |
Chemistry and Properties of Organic and Inorganic UV Filters | | 2008 |
Welche Information brauchen wir? | | 2005 |
Effects of religious and personal beliefs on medication regimen design | Orthopedics | 2011 |
Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis | Journal of Medical Internet Research | 2017 |
Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications | PLoS ONE | 2017 |
Contraceptive options and their associated estrogenic environmental loads: relationships and trade-offs | PLoS ONE | 2014 |
ADVERSE DRUG REACTIONS AND INTERACTIONS | | 2009 |
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation | Clinical Trials | 2021 |
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas | Cancer Chemotherapy and Pharmacology | 2021 |
Sustained virologic suppression with abacavir, emtricitabine, and crushed dolutegravir and tenofovir alafenamide in a patient with HIV and eosinophilic esophagitis | International Journal of STD and AIDS | 2020 |
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration | Cancer | 2020 |
Are patients more adherent to newer drugs? | Health Care Management Science | 2020 |
Scientific Considerations in the Approval of Complex Generics | AAPS Advances in the Pharmaceutical Sciences Series | 2019 |
Do cancer treatments have option value? Real-world evidence from metastatic melanoma | Health Economics (United Kingdom) | 2019 |
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis | BMC Medicine | 2019 |
A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications | Globalization and Health | 2019 |
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions | Pharmacoepidemiology and Drug Safety | 2019 |
Mechanochemistry for “no solvent, no base” preparation of hydantoin-based active pharmaceutical ingredients: nitrofurantoin and dantrolene | Green Chemistry | 2018 |
Immunophenotyping in Drug Development | | 2018 |
Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis | Pharmacoepidemiology and Drug Safety | 2018 |
The impact of self- and physician-administered cancer treatment on work productivity and healthcare utilization | Research in Social and Administrative Pharmacy | 2018 |
The VALID-project: Development of a new paediatric formulation of valaciclovir | International Journal of Pharmaceutics | 2018 |
Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk | Endocrine | 2018 |
Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014 | Clinical Pharmacology and Therapeutics | 2018 |
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development | Clinical and Translational Science | 2018 |
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension | Journal of Clinical Hypertension | 2018 |
American Diabetes Association's Standards of Care: A Paradigm Shift in the Dissemination of Information | Diabetes Care | 2018 |
Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report | BMC Psychiatry | 2017 |
BIBLIOGRAPHY AND REFERENCES | | 2017 |
Accelerated Pathways Work-Now What? A Survey of Payers in the United States | Therapeutic Innovation and Regulatory Science | 2017 |
Oral Contraception and Female Sexual Dysfunction in Reproductive Women | Sexual Medicine Reviews | 2017 |
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015 | PharmacoEconomics - Open | 2017 |
Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control | Diabetes Care | 2017 |
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir | British Journal of Clinical Pharmacology | 2017 |
Exploring the potential for using drug indications to prevent look-alike and sound-alike drug errors | Expert Opinion on Drug Safety | 2017 |
Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014 | Otolaryngology - Head and Neck Surgery | 2017 |
Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy | Hematological Oncology | 2017 |
Comparison of Testosterone Replacement Therapy Medications in the Treatment of Hypogonadism | Journal for Nurse Practitioners | 2017 |
Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions | Drugs | 2017 |
Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature | European Journal of Clinical Pharmacology | 2017 |